Optimizing Liver Transplant Allocation for Hepatocellular Carcinoma: Development and Validation of a Survival Benefit-Based Model.

March 1, 2026

View at Publisher

Ask AI

Bookmark

Share

Key Points

The aim is to develop and validate a model that predicts the survival benefit of liver transplantation for patients with unresectable hepatocellular carcinoma.
Development of the HCC-LTSB model based on existing data.
Validation of the model against UNOS criteria for liver transplantation.
Comparison with standard allocation methods.
The HCC-LTSB model accurately predicts survival benefit from liver transplantation.
It meets UNOS criteria for candidates with unresectable HCC.
Improved decision-making in patient selection for transplants.

Answers are grounded in this paper and cite their sources.

Model predicts survival benefit of liver transplants in patients with unresectable HCC, suggesting improved allocation strategies.

The HCC-LTSB model accurately predicted the survival benefit provided by LT in candidates listed with unresectable HCC within UNOS criteria.

No takes yet. Share an insight, caveat, or question.

Liu et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share